Source: Υπουργείο Υγείας (CY) Revision Year: 2020 Publisher: Delorbis Pharmaceuticals Ltd., 17 Athinon Street, Ergates Industrial Area, 2643 Ergates, P.O. Box 28629, 2081 Lefkosia, Cyprus, European Union
Fluxil 20 mg capsules.
| Pharmaceutical Form |
|---|
|
Capsules. Fluxil 20 mg capsules are light green and buff, hard gelatine capsules, size 3, containing white odourless powder. |
Each capsule contains fluoxetine hydrochloride (22.4 mg) equivalent to 20 mg of fluoxetine.
Excipient(s) with known effect: each capsule contains 146.60 mg of lactose monohydrate.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Fluoxetine |
Fluoxetine is a selective inhibitor of serotonin reuptake, and this probably accounts for the mechanism of action. Fluoxetine has practically no affinity to other receptors such as α1 |
| List of Excipients |
|---|
|
Capsule content: Microcrystalline cellulose Hard gelatin capsule shell composition: Titanium dioxide |
Fluoxetine 20 mg capsules are supplied in Alu/PVC-PVDC blister packs of 1x10 or 3x10 capsules.
Not all pack sizes may be marketed.
Delorbis Pharmaceuticals Ltd., 17 Athinon Street, Ergates Industrial Area, 2643 Ergates, P.O. Box 28629, 2081 Lefkosia, Cyprus, European Union
Fluxil 20 mg capsules: 019991
Date of first authorisation: 29 December 2005
| Drug | Countries | |
|---|---|---|
| FLUXIL | Albania, Cyprus, Hong Kong, Malta, Singapore |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
